{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-427224","form_type":"8-K","ticker":"VYGR","cik":"0001640266","company_name":"Voyager Therapeutics, Inc.","filed_at":"2026-10-21T12:07:22+00:00","discovered_at":"2026-10-21T12:10:00.318345+00:00","generated_at":"2026-10-21T12:10:04.466852+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Voyager Therapeutics names Robin Swartz President; slated to succeed CEO Sandrock after Q1 2027 VY1706 safety data","bullets":["Swartz, 56, becomes President effective Oct 20, 2026; she has been COO and Chief Business Officer since Nov 2024 and Principal Financial Officer/Treasurer since May 2026.","CEO transition expected after initial acute safety data from the VY1706 trial in early Alzheimer's, anticipated in Q1 2027; Alfred Sandrock is expected to remain on the Board.","Swartz base salary $625,000 with a 50% target bonus; she receives an option for 318,500 shares and 68,250 RSUs granted Nov 1, 2026 under the 2025 Stock Incentive Plan.","Severance on termination without cause or for good reason: 12 months base salary, pro rata target bonus and up to 12 months COBRA; full equity acceleration if within 12 months after a sale event."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-427224","json":"https://secwatch.observer/filing/0001193125-26-427224.json","markdown":"https://secwatch.observer/filing/0001193125-26-427224.md","text":"https://secwatch.observer/filing/0001193125-26-427224.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1640266/000119312526427224/0001193125-26-427224-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1640266/000119312526427224/d157795d8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-21T12:10:04.466852+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}